Regulatory & Compliance

The recent announcement from the Food and Drug Administration concerning the critical safety risks of Abiomed’s Impella heart pumps highlights a significant vulnerability in high-stakes cardiac intervention technology. At the heart of this regulatory alert lies a defect in the first-generation

James Maitland is a distinguished authority on federal health administration and the integration of advanced technology within healthcare ecosystems. With an extensive background in overseeing complex billing structures and a passion for leveraging robotics and IoT to streamline medical services,

When a manufacturer responsible for critical medical device components experiences a total halt in its digital operations, the consequences ripple far beyond the walls of its corporate headquarters and into the healthcare facilities that rely on its timely deliveries. UFP Technologies, a prominent

Navigating the Aftermath of Regulatory Scrutiny The sudden termination of a high-stakes federal investigation often marks the difference between a corporate collapse and a remarkable operational resurrection for firms in the healthcare sector. Veradigm recently reached a pivotal milestone by

The American healthcare landscape is currently facing a precarious financial reckoning as the Congressional Budget Office significantly accelerates its timeline for the exhaustion of the Medicare Hospital Insurance trust fund. This drastic revision, which pulls the projected insolvency date forward

As the landscape of American healthcare shifts, the once-frenzied expansion of Medicare Advantage is entering a period of sobering recalibration. With decades of experience navigating the labyrinth of federal healthcare policy and the strategic maneuvers of private insurers, our expert provides a